Zepbound Approved: Weight Loss & Sleep Apnea Breakthrough
Zepbound Approved: Weight Loss & Sleep Apnea Breakthrough The U.S. Food and Drug Administration (FDA) has recently approved the weight-loss drug Zepbound (bimagrumab). This marks a significant step forward in treating obesity-related conditions. Importantly, Zepbound will help patients manage obstructive sleep apnea (OSA), which is often linked to obesity. What is Zepbound? Zepbound, created by…
